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Autologous bone marrow mononuclear cell
therapy is safe and promotes amputation-free
survival in patients with critical limb ischemia
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ACellular therapies for critical limb ischemia (CLI) have
been shown in multiple reports to improve perfusion and
limb salvage where patients were deemed unsuitable for
conventional therapy. The procedure which involves bone
marrow aspirate for CLI requires a comprehensive under-
standing of vascular disease to allow for appropriate patient
selection, preprocedure planning, intraoperative marking,
and delivery of the cellular concentrate in a perivascular
space under continuous ultrasound guidance. The clinical
trials to date, in the majority of patients, have the bone
marrow aspiration performed by a hematologist. The re-
mainder of the service description is performed by the
vascular specialist. However, some centers prefer that one
individual does both the bone marrow aspiration as well as
the injection therapy. Currently, there are no descriptions
in the CPT manual appropriate for reporting this novel
technique. Therefore, unless an insurance carrier indicates
otherwise, the unlisted vascular procedure CPT code
(37799) is most appropriate for all or part of this interven-
tion. This will require submission of medical records and be
subject to review by a medical director.
On January 1, 2011, a new set of three Category III
CPT codes were released for implementation on July 1,
2011. Category III CPT codes (also called “T” codes) are
created for emerging technology that has not yet obtained
approval from the U.S. Food and Drug Administration
(FDA). As with the majority of Category III codes, they
will undoubtedly be valued at $0 in the Medicare Physi-
cian’s Fee Schedule, although regional carriers may choose
to reimburse on a case-by-case basis. Once FDA-approval is
achieved, conversion to Category I status will soon follow.
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1750CPT code 0263T states “Intramuscular autologous
one marrow cell therapy, with preparation of harvested cells,
ultiple injections, one leg, including ultrasound guidance,
f performed; complete procedure including unilateral or
ilateral bone marrow harvest.” This describes the entire
rocedure when both the bone marrow aspiration as well as
he subsequent injection is accomplished by a single prac-
itioner. The next two codes each describe a portion of the
ervice. They are only appropriate for submission to the
nsurance carrier when an individual completes only that
escribed segment of the operation. CPT code 0264T
“Intramuscular autologous bone marrow cell therapy, with
reparation of harvested cells, multiple injections, one leg,
ncluding ultrasound guidance, if performed; complete pro-
edure excluding bone marrow harvest”) encompasses all
spects of the procedure except the retrieval of bone mar-
ow from either one or both iliac crests. Lastly, CPT code
265T (“Intramuscular autologous bone marrow cell ther-
py, with preparation of harvested cells, multiple injections,
ne leg, including ultrasound guidance, if performed; uni-
ateral or bilateral bone marrow harvest only for intramus-
ular autologous bone marrow cell therapy”) describes uni-
ateral or bilateral bone marrow harvest specifically in
onjunction with bone marrow aspiration/injection for
LI. There are several other Category I CPT codes that
ddress procurement of bone marrow. The creation of
hese new Category III codes ensures that none of those
ther bone marrow harvest codes are appropriate to report
hen performed in this setting.
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